Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
CIG Media Group
Access Rights
info:eu-repo/semantics/closedAccess
DOI
Abstract
Description
Keywords
Journal or Series
Clinical Lymphoma, Myeloma & Leukemia
WoS Q Value
Scopus Q Value
Volume
22
Issue
Citation
Fıratlı Tuğlular, A. T., Pehlivan, M., Sönmez, M., Kabukçu Hacıoğlu, S., Saydam, G., Ayyıldız, O. ... Beksaç, M. (2022). Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey. Clinical Lymphoma, Myeloma & Leukemia içinde (S190-S191. ss.).
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
